RNF5 inhibitor inh-02
≥98%
- Product Code: 124814
CAS:
324579-65-9
| Molecular Weight: | 384.5 g./mol | Molecular Formula: | C₂₃H₂₀N₄S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, dry, sealed |
Product Description:
RNF5 inhibitor inh-02 is primarily utilized in research focused on understanding and modulating protein degradation pathways, particularly those involving the RNF5 E3 ubiquitin ligase. This compound is employed in studies investigating cellular stress responses, protein quality control mechanisms, and the role of ubiquitination in diseases such as cancer, neurodegenerative disorders, and immune-related conditions. By inhibiting RNF5, researchers can explore its impact on the stabilization of misfolded proteins, endoplasmic reticulum (ER) stress, and the regulation of key signaling pathways. Additionally, it serves as a tool to evaluate potential therapeutic strategies targeting ubiquitin-proteasome system dysregulation. Its application is largely confined to preclinical and laboratory settings, aiding in the development of novel treatments for conditions linked to defective protein homeostasis.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | Ft252,502.00 |
+
-
|
RNF5 inhibitor inh-02
RNF5 inhibitor inh-02 is primarily utilized in research focused on understanding and modulating protein degradation pathways, particularly those involving the RNF5 E3 ubiquitin ligase. This compound is employed in studies investigating cellular stress responses, protein quality control mechanisms, and the role of ubiquitination in diseases such as cancer, neurodegenerative disorders, and immune-related conditions. By inhibiting RNF5, researchers can explore its impact on the stabilization of misfolded proteins, endoplasmic reticulum (ER) stress, and the regulation of key signaling pathways. Additionally, it serves as a tool to evaluate potential therapeutic strategies targeting ubiquitin-proteasome system dysregulation. Its application is largely confined to preclinical and laboratory settings, aiding in the development of novel treatments for conditions linked to defective protein homeostasis.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :